Want to see SLSN full AI Analyst Report?
SLSN Stock Chart & Stats
$0.95
$0.04(4.26%)
At close: 4:00 PM EDT
$0.95
$0.04(4.26%)
Day’s Range― - ―
52-Week Range$0.61 - $4.00
Previous CloseN/A
Volume5.30K
Average Volume (3M)22.49K
Market Cap
$72.06M
Enterprise Value$73.57M
Total Cash (Recent Filing)$1.05M
Total Debt (Recent Filing)$22.70M
Price to Earnings (P/E)―
Beta1.96
Next Earnings
Nov 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding70,647,040
10 Day Avg. Volume32,729
30 Day Avg. Volume22,490
Financial Highlights & Ratios
PEG Ratio-0.93
Price to Book (P/B)6.38
Price to Sales (P/S)1.81
P/FCF Ratio-10.51
Enterprise Value/Market Cap1.02
Enterprise Value/Revenue1.33
Enterprise Value/Gross Profit4.95
Enterprise Value/Ebitda791.10
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Product Innovation And Market ExpansionThe scalp-care launches extend Solesence beyond its established personal-care applications and apply existing delivery technology to a sizable adjacent market. If early interest converts into commercial demand, this broader product platform could diversify revenue and support longer-term growth.
Growing Order Book And Revenue OutlookYear-over-year growth in shipped and on-hand orders provides evidence of customer demand beyond a single reporting period. Management’s full-year outlook and planned second-half improvement indicate a potential revenue recovery, supporting better utilization and operating leverage.
Extended Affiliate Loan MaturitiesExtending the maturities gives Solesence more time before substantial affiliate debt becomes due and reduces immediate refinancing pressure. The longer financing horizon can improve liquidity planning and preserve capacity to execute product and operational initiatives while earnings recover.
Bears Say
Revenue And Profitability DeteriorationThe recent reversal from growth and positive earnings to lower revenue and losses signals weakened demand or execution and reduces internal funding capacity. Continued underperformance could prevent fixed costs from being absorbed efficiently and make the recovery outlook less durable.
Negative And Volatile Free Cash FlowNegative free cash flow limits the cash available to fund growth, repay debt, or absorb operating setbacks without external financing. The historical volatility and inconsistent profit-to-cash conversion also indicate that reported earnings may not reliably translate into financial flexibility.
Nasdaq Listing Compliance RiskFailure to restore compliance by the stated deadline could lead to delisting and make future capital raising more difficult. That risk is material because weaker market access could constrain liquidity, financing flexibility, and the company’s ability to support operations.
Solesence News
SLSN FAQ
What was Solesence’s price range in the past 12 months?
Solesence lowest stock price was $0.61 and its highest was $4.00 in the past 12 months.
What is Solesence’s market cap?
Solesence’s market cap is $72.06M.
When is Solesence’s upcoming earnings report date?
Solesence’s upcoming earnings report date is Nov 04, 2026 which is in 24 days.
How were Solesence’s earnings last quarter?
Solesence released its earnings results on Aug 19, 2026. The company reported -$0.002 earnings per share for the quarter.
Is Solesence overvalued?
According to Wall Street analysts Solesence’s price is currently Overvalued.
Does Solesence pay dividends?
Solesence does not currently pay dividends.
What is Solesence’s EPS estimate?
Solesence’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Solesence have?
Solesence has 70,647,040 shares outstanding.
What happened to Solesence’s price movement after its last earnings report?
Solesence reported an EPS of -$0.002 in its last earnings report. Following the earnings report the stock price went up 5.319%.
Which hedge fund is a major shareholder of Solesence?
Currently, no hedge funds are holding shares in SLSN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Solesence Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
SLSN Sentiment 100%
Sector Average 64%
Sector Average 64%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-77.76%
12-Months-Change
Fundamentals
Return on Equity
-11.58%
Trailing 12-Months
Asset Growth
-22.55%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Solesence
Solesence, Inc., formerly known as Nanophase Technologies Corporation, specializes in the development and production of clean-label, inclusive, and mineral-based skincare and cosmetic products. The company collaborates with a diverse range of partners, from major global corporations to independent brands, employing its unique Active Stress Defense™ technology suite. Through this proprietary system, Solesence brings innovative beauty solutions to the market that provide effective environmental protection.
SLSN Company Deck
SLSN Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a mixed picture: materially weaker reported Q2 revenue and profitability and a significant accounting remediation (inventory costing restatements) are clear negatives that expose historical control weaknesses and distorted year-over-year comparatives. Offsetting this, management highlights tangible operational improvements (labor efficiency, OEE), a growing order book (shipped and on-hand orders up ≈8.2% year-over-year), new product launches targeting sizable addressable markets, and confident guidance for a stronger second half and full-year outperformance versus 2025. Management has committed to remediation actions and control enhancements. Overall, positives around backlog growth, product pipeline, and remediation efforts balance the near-term financial and control challenges.View all SLSN earnings summariesTechnical Analysis
Ownership Overview
5.90% Insiders
2.03% Mutual Funds
0.27% Other Institutional Investors
90.57% Public Companies and
Individual Investors